EMEA-001232-PIP01-11
Key facts
Active substance |
|
Therapeutic area |
Cardiovascular diseases
|
Decision number |
P/0103/2012
|
PIP number |
EMEA-001232-PIP01-11
|
Pharmaceutical form(s) |
Tablet
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
GlaxoSmithKline Trading Services Limited
United Kingdom
admin@wainwrightassociates.co.uk +44 1628530554 |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|